TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development
TBVAC2020 is a research project supported by the Horizon 2020 program of the European Commission (EC). It aims at the discovery and development of novel tuberculosis (TB) vaccines from preclinical research projects to early clinical assessment. The project builds on previous collaborations from 1998...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Frontiers Media
2017
|
| _version_ | 1826286279269023744 |
|---|---|
| author | Kaufmann, S Dockrell, H Drager, N Ho, M McShane, H Neyrolles, O Ottenhoff, T Patel, B Roordink, D Spertini, F Stenger, S Thole, J Verreck, F Williams, A Consortium, T |
| author_facet | Kaufmann, S Dockrell, H Drager, N Ho, M McShane, H Neyrolles, O Ottenhoff, T Patel, B Roordink, D Spertini, F Stenger, S Thole, J Verreck, F Williams, A Consortium, T |
| author_sort | Kaufmann, S |
| collection | OXFORD |
| description | TBVAC2020 is a research project supported by the Horizon 2020 program of the European Commission (EC). It aims at the discovery and development of novel tuberculosis (TB) vaccines from preclinical research projects to early clinical assessment. The project builds on previous collaborations from 1998 onwards funded through the EC framework programs FP5, FP6, and FP7. It has succeeded in attracting new partners from outstanding laboratories from all over the world, now totaling 40 institutions. Next to the development of novel vaccines, TB biomarker development is also considered an important asset to facilitate rational vaccine selection and development. In addition, TBVAC2020 offers portfolio management that provides selection criteria for entry, gating, and priority settings of novel vaccines at an early developmental stage. The TBVAC2020 consortium coordinated by TBVI facilitates collaboration and early data sharing between partners with the common aim of working toward the development of an effective TB vaccine. Close links with funders and other consortia with shared interests further contribute to this goal. |
| first_indexed | 2024-03-07T01:41:24Z |
| format | Journal article |
| id | oxford-uuid:96f77f67-d412-4384-a655-96c19bf592f5 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T01:41:24Z |
| publishDate | 2017 |
| publisher | Frontiers Media |
| record_format | dspace |
| spelling | oxford-uuid:96f77f67-d412-4384-a655-96c19bf592f52022-03-26T23:56:32ZTBVAC2020: Advancing tuberculosis vaccines from discovery to clinical developmentJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:96f77f67-d412-4384-a655-96c19bf592f5Symplectic Elements at OxfordFrontiers Media2017Kaufmann, SDockrell, HDrager, NHo, MMcShane, HNeyrolles, OOttenhoff, TPatel, BRoordink, DSpertini, FStenger, SThole, JVerreck, FWilliams, AConsortium, TTBVAC2020 is a research project supported by the Horizon 2020 program of the European Commission (EC). It aims at the discovery and development of novel tuberculosis (TB) vaccines from preclinical research projects to early clinical assessment. The project builds on previous collaborations from 1998 onwards funded through the EC framework programs FP5, FP6, and FP7. It has succeeded in attracting new partners from outstanding laboratories from all over the world, now totaling 40 institutions. Next to the development of novel vaccines, TB biomarker development is also considered an important asset to facilitate rational vaccine selection and development. In addition, TBVAC2020 offers portfolio management that provides selection criteria for entry, gating, and priority settings of novel vaccines at an early developmental stage. The TBVAC2020 consortium coordinated by TBVI facilitates collaboration and early data sharing between partners with the common aim of working toward the development of an effective TB vaccine. Close links with funders and other consortia with shared interests further contribute to this goal. |
| spellingShingle | Kaufmann, S Dockrell, H Drager, N Ho, M McShane, H Neyrolles, O Ottenhoff, T Patel, B Roordink, D Spertini, F Stenger, S Thole, J Verreck, F Williams, A Consortium, T TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development |
| title | TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development |
| title_full | TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development |
| title_fullStr | TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development |
| title_full_unstemmed | TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development |
| title_short | TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development |
| title_sort | tbvac2020 advancing tuberculosis vaccines from discovery to clinical development |
| work_keys_str_mv | AT kaufmanns tbvac2020advancingtuberculosisvaccinesfromdiscoverytoclinicaldevelopment AT dockrellh tbvac2020advancingtuberculosisvaccinesfromdiscoverytoclinicaldevelopment AT dragern tbvac2020advancingtuberculosisvaccinesfromdiscoverytoclinicaldevelopment AT hom tbvac2020advancingtuberculosisvaccinesfromdiscoverytoclinicaldevelopment AT mcshaneh tbvac2020advancingtuberculosisvaccinesfromdiscoverytoclinicaldevelopment AT neyrolleso tbvac2020advancingtuberculosisvaccinesfromdiscoverytoclinicaldevelopment AT ottenhofft tbvac2020advancingtuberculosisvaccinesfromdiscoverytoclinicaldevelopment AT patelb tbvac2020advancingtuberculosisvaccinesfromdiscoverytoclinicaldevelopment AT roordinkd tbvac2020advancingtuberculosisvaccinesfromdiscoverytoclinicaldevelopment AT spertinif tbvac2020advancingtuberculosisvaccinesfromdiscoverytoclinicaldevelopment AT stengers tbvac2020advancingtuberculosisvaccinesfromdiscoverytoclinicaldevelopment AT tholej tbvac2020advancingtuberculosisvaccinesfromdiscoverytoclinicaldevelopment AT verreckf tbvac2020advancingtuberculosisvaccinesfromdiscoverytoclinicaldevelopment AT williamsa tbvac2020advancingtuberculosisvaccinesfromdiscoverytoclinicaldevelopment AT consortiumt tbvac2020advancingtuberculosisvaccinesfromdiscoverytoclinicaldevelopment |